Ocugen (OCGN) Change in Cash (2014 - 2026)
Ocugen posted quarterly Change in Cash of $13.3 million for Q1 2026, up 164.15% year-on-year from $5.0 million in Q1 2025, and up 194.96% on a QoQ basis from -$14.0 million in Q4 2025.
Ocugen (OCGN) has 13 years of Change in Cash data on file, last reported at $13.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 164.15% year-over-year to $13.3 million; the trailing twelve-month figure through Mar 2026 stood at -$5.9 million (down 150.59% YoY), and the FY2025 full-year result was -$39.9 million, down 306.28% from the prior year.
- Change in Cash for Q1 2026 stood at $13.3 million, up from -$14.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $34.8 million in Q1 2022 and bottomed at -$24.0 million in Q4 2022.
- The 5-year median for Change in Cash is -$10.8 million (2025), against an average of -$3.7 million.
- Peak annual rise in Change in Cash reached 241.42% in 2024, while the deepest fall reached 547.43% in 2024.
- A 5-year view of Change in Cash shows it stood at -$24.0 million in 2022, then jumped by 41.7% to -$14.0 million in 2023, then soared by 241.42% to $19.8 million in 2024, then plunged by 170.59% to -$14.0 million in 2025, then surged by 194.96% to $13.3 million in 2026.
- The last three Change in Cash figures came in at $13.3 million (Q1 2026), -$14.0 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | 13.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.29 Mn |
| Dec 31, 2025 | -13.99 Mn |
| Sep 30, 2025 | 5.55 Mn |
| Jun 30, 2025 | -10.79 Mn |
| Mar 31, 2025 | -20.71 Mn |
| Dec 31, 2024 | 19.82 Mn |
| Sep 30, 2024 | 23.00 Mn |
| Jun 30, 2024 | -10.38 Mn |
| Mar 31, 2024 | -13.09 Mn |
| Dec 31, 2023 | -14.02 Mn |
| Sep 30, 2023 | -17.10 Mn |
| Jun 30, 2023 | 2.32 Mn |
| Mar 31, 2023 | -9.30 Mn |
| Dec 31, 2022 | -24.04 Mn |
| Sep 30, 2022 | -13.40 Mn |
| Jun 30, 2022 | -14.92 Mn |
| Mar 31, 2022 | 34.81 Mn |
| Dec 31, 2021 | -12.39 Mn |
| Sep 30, 2021 | -8.29 Mn |
| Jun 30, 2021 | 70.85 Mn |
| Mar 31, 2021 | 20.75 Mn |
| Dec 31, 2020 | 4.93 Mn |
| Sep 30, 2020 | 4.14 Mn |
| Jun 30, 2020 | 11.78 Mn |
| Mar 31, 2020 | -4.25 Mn |
| Dec 31, 2019 | -7.86 Mn |
| Sep 30, 2019 | 14.62 Mn |
| Jun 30, 2019 | 369,926.00 |
| Mar 31, 2019 | -1.32 Mn |
| Dec 31, 2018 | -855,464.00 |
| Sep 30, 2018 | -5.36 Mn |
| Jun 30, 2018 | -6.74 Mn |
| Mar 31, 2018 | 8.43 Mn |
| Dec 31, 2017 | -3.72 Mn |
| Sep 30, 2017 | 236,000.00 |
| Jun 30, 2017 | -5.81 Mn |
| Mar 31, 2017 | -15.53 Mn |
| Dec 31, 2016 | -6.09 Mn |
| Sep 30, 2016 | 22.07 Mn |
| Jun 30, 2016 | -6.97 Mn |
| Mar 31, 2016 | -8.02 Mn |
| Dec 31, 2015 | -7.28 Mn |
| Sep 30, 2015 | -7.50 Mn |
| Jun 30, 2015 | -7.96 Mn |
| Mar 31, 2015 | -4.88 Mn |
| Dec 31, 2014 | 55.27 Mn |
| Sep 30, 2014 | -4.52 Mn |
| Jun 30, 2014 | 4.42 Mn |
| Mar 31, 2014 | -5.37 Mn |